Innatoss and MediSapiens Receive EU Grant to Personalize Lyme Diagnostics
Innatoss and MediSapiens have partnered to develop a novel Lyme borreliosis clinical interpretation and communication solution. The development is supported by the PERMIDES (Personalised Medicine Innovation through Digital Enterprise Solutions) project, funded by the European Union.
Better communication and analysis of Lyme tests
The partnership aims at developing a novel solution for analyzing and reporting LB diagnostics results and clinical development in a convenient and readily comprehensible manner. The diagnostics of LB is complex, and often requires multiple different parallel and subsequent tests. Untreated LB can lead to serious health problems. Communicating the results in an easily understandable and actionable manner is pivotal for timely clinical decision making optimal patient management.
Read more on this project.